Clinical Trial Update: A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer

View source ↗

Summary

A multicenter registry study led by Fudan University to evaluate unresectable stage III hepatocellular carcinoma (CNLC) in liver cancer. The trial status is NOT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Fudan University | Conditions: Unresectable Hepatocellular Carcinoma | Status: NOT_YET_RECRUITING